Jeffrey Fink - Jun 5, 2024 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Director
Signature
/s/ Jeffrey Fink
Stock symbol
LPCN
Transactions as of
Jun 5, 2024
Transactions value $
$12,436
Form type
4
Date filed
6/7/2024, 05:39 PM
Previous filing
May 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Common Stock (Right to Buy) Award $12.4K +1.76K +19.23% $7.05 10.9K Jun 5, 2024 Common Stock 1.76K $7.05 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

1. 100% vesting one year from date of grant.